NCT05273307View on ClinicalTrials.gov

Addressing Taste Dysfunction With Miraculin in Head and Neck Cancer Patients Receiving Radiation Therapy

PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 4, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Head and Neck CancerTaste Dysfunction
Interventions
DIETARY_SUPPLEMENT

Miraculin

Given orally

DIETARY_SUPPLEMENT

Miracle Fruit Placebo Cube

Given orally

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

Miracle Fruit Farm

UNKNOWN

collaborator

Mount Zion Health Fund

OTHER

lead

University of California, San Francisco

OTHER